AppliedVR
Pioneering virtual reality therapeutics.
Pioneering virtual reality therapeutics.
AppliedVR is a healthcare startup that is pioneering immersive therapeutics (ITx) using virtual reality technology to treat chronic pain and behavioral and mental health disorders. Their flagship product, RelieVRx, has received Breakthrough Therapy Designation and De Novo authorization by the FDA for chronic lower back pain. The company has gained the trust of over 200 leading health systems and thousands of healthcare professionals globally, treating more than 60,000 patients. Founded in 2015 and headquartered in the United States, AppliedVR recently received a $36.00M Series B investment on 11 November 2021 from F-Prime Capital, Sway Ventures, Jazz Venture Partners, and SVB Capital. AppliedVR's innovative approach, impressive track record, and strategic partnerships position it as a promising player in the evolving landscape of healthcare technology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $36.00M | 4 |
|
11 Nov 2021 |
| Series A | $29.00M | 6 |
|
23 Mar 2021 |
| Seed Round | $6.00M | - | 28 Mar 2016 |
No recent news or press coverage available for AppliedVR.
We care about your data, and we'd love to use cookies make your experience better.
